Combining corporate finance expertise with diverse technology, healthcare, life sciences and real estate practices, lawyers at Morrison & Foerster's Hong Kong, Beijing, and Shanghai offices are very active in all aspects of the evolving private equity market in China. We regularly represent private equity investors, venture capitalists, private equity fund sponsors and issuers in a wide variety of private equity transactions, including buy-outs (leveraged and non-leveraged), early and late-stage venture investments, and restructurings and recapitalizations.
The firm is recognized as a leading law firm for private equity and venture capital in China and Hong Kong by independent ranking organizations such as Legal 500 Asia Pacific, Chambers Asia, Chambers Global, IFLR1000, Asian Legal Business, and China Law & Practice. Chambers Asia Pacific 2018 says, “We’re very happy with the practice – the partners speak Chinese and understand the local and international business and cultural environment.” Legal 500 2018 adds that, “Morrison & Foerster enjoys long-term relationships with some of China’s leading private equity entities and major multinational private equity funds that invest in China”.
For more information on our Private Funds practice, please see Private Funds.
Chambers Global 2018Asia-Pacific: Corporate/M&A: Private Equity
Chambers Asia-Pacific 2018Asia-wide: Corporate/M&A: Private EquityChina: Private Equity: Buyouts: International Firms
IFLR1000 2018China: Private Equity: Foreign Firms Hong Kong: Private Equity
Legal 500 Asia-Pacific 2018China: Private Equity/Venture Capital: Foreign FirmsHong Kong: Private Equity
ALB Hong Kong Law Awards 2018Deal Firm of the Year
China Law & Practice 2018Private Equity Deal of the Year
Here is what they say about us:
"Deft handling of venture capital and private equity mandates for key Chinese and international investors, with a strong focus on regional funds. Especially noted for deep experience on outbound investment into US targets. Active in sectors such as technology, healthcare and pharmaceuticals."(Chambers Asia-Pacific 2018)
Chambers Asia Pacific
Deft handling of venture capital and private equity mandates for key Chinese and international investors, with a strong focus on regional funds. Especially noted for deep experience on outbound investment into US targets. Active in sectors such as technology, healthcare and pharmaceuticals.
“Given its impressive regional reputation, the firm is able to attract high-profile clients. Clients appreciate the firm’s ‘excellent track record of exposure to a range of deals and issues,’ and also cite the presence of Chinese lawyers with experience at international firms as evidence of its ability to bridge the local and international divide.”
“We’re very happy with the practice – the partners speak Chinese and understand the local and international business and cultural environment."
“Outstanding for international fund formation and China work.”
©1996-2019 Morrison & Foerster LLP. All rights reserved.